Valuation: Enovis Corporation

Market Cap 1.47B 1.29B 1.19B 1.09B 2.07B 142B 2.11B 14.2B 5.57B 69.21B 5.53B 5.41B 239B P/E 2026 *
234x
P/E 2027 * 29.1x
Enterprise Value 2.67B 2.33B 2.16B 1.98B 3.75B 257B 3.82B 25.73B 10.09B 125B 10.03B 9.81B 434B EV / Sales 2026 *
1.14x
EV / Sales 2027 * 1.03x
Free-Float
98.38%
Yield 2026 *
-
Yield 2027 * -
1 day+9.69%
1 week+18.79%
Current month+35.60%
1 month+33.79%
3 months+10.82%
6 months+15.70%
Current year+5.37%
1 week 24.45
Extreme 24.45
28.16
1 month 19.14
Extreme 19.14
28.16
Current year 19.14
Extreme 19.14
29.89
1 year 19.14
Extreme 19.14
34.28
3 years 19.14
Extreme 19.14
66.14
5 years 19.14
Extreme 19.14
164.01
10 years 19.14
Extreme 19.14
164.01
Manager TitleAgeSince
Chief Executive Officer 61 11/05/2025
Director of Finance/CFO 47 31/12/2022
Chief Tech/Sci/R&D Officer - 31/12/2025
Director TitleAgeSince
Director/Board Member 55 12/05/2008
Director/Board Member 67 20/09/2010
Chairman 64 20/05/2025
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

846 0.0015%
15/06/26 Buy

Chief Administrative Officer

1,000 0.0017%
11/06/26 Buy

Chief Administrative Officer

1,200 0.0021%
Change 5-day change 1-year change 3-year change Capi.($)
+9.69%+18.79%-9.16%-56.97% 1.47B
+4.66%+1.33%-15.21%+9.51% 121B
+1.04%+3.29%+5.78%-1.44% 13.07B
-0.92%+1.59%+58.14%+96.47% 9.21B
+3.39%+12.27%-43.55%-69.82% 4.2B
-1.12%+10.06%+14.61%+52.41% 2.91B
-0.07%-2.56%-15.45%-27.09% 1.73B
+0.73%+4.88%-4.51%-19.41% 1.67B
+2.06%+4.54%-59.73%-84.19% 1.46B
Average +2.16%+3.35%-7.68%-11.17% 17.45B
Weighted average by Cap. +3.82%-1.70%-9.61%+10.17%

Financials

2026 *2027 *
Net sales 2.34B 2.05B 1.9B 1.74B 3.29B 226B 3.35B 22.59B 8.86B 110B 8.8B 8.61B 381B 2.47B 2.15B 1.99B 1.83B 3.46B 238B 3.52B 23.76B 9.32B 116B 9.26B 9.06B 400B
Net income 2.96M 2.59M 2.39M 2.2M 4.16M 285M 4.23M 28.53M 11.19M 139M 11.11M 10.87M 481M 54.22M 47.38M 43.84M 40.24M 76.13M 5.22B 77.49M 523M 205M 2.55B 204M 199M 8.8B
Net Debt 1.2B 1.05B 968M 889M 1.68B 115B 1.71B 11.54B 4.53B 56.26B 4.5B 4.4B 194B 1.07B 932M 862M 791M 1.5B 103B 1.52B 10.27B 4.03B 50.08B 4B 3.91B 173B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
16/07/26 US$28.07 +9.69% 1,369,822
15/07/26 US$25.59 +3.81% 993,978
14/07/26 US$24.65 -6.10% 859,530
13/07/26 US$26.25 +1.94% 914,625
10/07/26 US$25.75 +2.10% 768,242
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
28.07USD
Average target price
40.73USD
Spread / Average Target
+45.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock